Literature DB >> 18983932

Plant-produced vaccines: promise and reality.

Edward P Rybicki1.   

Abstract

Plant-produced vaccines are a much-hyped development of the past two decades, whose time to embrace reality may have finally come. Vaccines have been developed against viral, bacterial, parasite and allergenic antigens, for humans and for animals; a wide variety of plants have been used for stable transgenic expression as well as for transient expression via Agrobacterium tumefaciens and plant viral vectors. A great many products have shown significant immunogenicity; several have shown efficacy in target animals or in animal models. The realised potential of plant-produced vaccines is discussed, together with future prospects for production and registration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983932     DOI: 10.1016/j.drudis.2008.10.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  51 in total

1.  Production of highly concentrated, heat-stable hepatitis B surface antigen in maize.

Authors:  Celine A Hayden; Erin M Egelkrout; Alessa M Moscoso; Cristina Enrique; Todd K Keener; Rafael Jimenez-Flores; Jeffrey C Wong; John A Howard
Journal:  Plant Biotechnol J       Date:  2012-07-21       Impact factor: 9.803

Review 2.  The effect of the unfolded protein response on the production of recombinant proteins in plants.

Authors:  David Rhys Thomas; Amanda Maree Walmsley
Journal:  Plant Cell Rep       Date:  2014-09-04       Impact factor: 4.570

Review 3.  Norwalk virus-like particles as vaccines.

Authors:  Melissa Herbst-Kralovetz; Hugh S Mason; Qiang Chen
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

4.  Improved expression of recombinant plant-made hEGF.

Authors:  David Rhys Thomas; Amanda Maree Walmsley
Journal:  Plant Cell Rep       Date:  2014-07-22       Impact factor: 4.570

Review 5.  Progress towards a needle-free hepatitis B vaccine.

Authors:  Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

Review 6.  HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.

Authors:  Luciano Mariani; Aldo Venuti
Journal:  J Transl Med       Date:  2010-10-27       Impact factor: 5.531

7.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast.

Authors:  Mauro Morgenfeld; María Eugenia Segretin; Sonia Wirth; Ezequiel Lentz; Alicia Zelada; Alejandro Mentaberry; Lutz Gissmann; Fernando Bravo-Almonacid
Journal:  Mol Biotechnol       Date:  2009-07-05       Impact factor: 2.695

9.  High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants.

Authors:  Ezequiel Matías Lentz; María Eugenia Segretin; Mauro Miguel Morgenfeld; Sonia Alejandra Wirth; María José Dus Santos; Marina Valeria Mozgovoj; Andrés Wigdorovitz; Fernando Félix Bravo-Almonacid
Journal:  Planta       Date:  2009-11-22       Impact factor: 4.116

10.  Cotton Leaf Curl Multan Betasatellite DNA as a Tool to Deliver and Express the Human B-Cell Lymphoma 2 (Bcl-2) Gene in Plants.

Authors:  Sara Kharazmi; Elham Ataie Kachoie; Seyed Ali Akbar Behjatnia
Journal:  Mol Biotechnol       Date:  2016-05       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.